pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›timolol
drug · small molecule
save

timolol

Phase 2updated 3mo ago
by Betaliq Inc🔗 ChEMBL
Phase 2
community read0 votes

🐶 often sniffed alongside

top 8
  • drugBetimol8 co-mentions · 8 sources
  • tagRecall8 co-mentions · 8 sources
  • drugCusimolol8 co-mentions · 8 sources
  • drugIstalol8 co-mentions · 8 sources
  • drugtimolol maleate8 co-mentions · 8 sources
  • drugtimolol maleate LA8 co-mentions · 8 sources
  • drugTimoptic8 co-mentions · 8 sources
  • drugtimolol maleate ER8 co-mentions · 8 sources

Small molecule drug with a maximum clinical stage of Approval (across all indications), with 5 approved and 10 investigational indications.

targets

Beta-1 adrenergic receptorBeta-2 adrenergic receptor

all catalysts(0)

nothing on the calendar yet

Trials studying timolol

  • phase2Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertensioncompletedn=252
  • phase4Dorzolamide/Brimonidine/Timolol Impact on Ocular Surface, Glaucoma Progression & Chatbot Follow-up: GLAUCO-TECHactive not recruitingn=140
  • phase2Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinibactive not recruitingn=305
  • phase2Study of an Investigational Product, QLS-111, Provided as an Eyedrop, for Treatment of Normal Tension Glaucoma (NTG)completedn=37
  • phase3Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implantrecruitingn=510
  • phase3Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implantrecruitingn=610
  • phase3Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)recruitingn=400
  • phase3Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)recruitingn=400
more trials →

News(0)

no news has mentioned this drug yet

trade names
Betim, Betimol, Blocadren, Glau-opt, Glaucol, Nyogel
generic
timolol
MOA
Beta-1 adrenergic receptor antagonist; Beta-2 adrenergic receptor antagonist
indication
Ocular Hypertension
phase
phase_2
Data sources
ClinicalTrials.gov · OpenTargets
last refreshed 8m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?